Bristol-Myers Squibb (BMY) and Otsuka Pharmaceutical Announce Long …
StreetInsider.com - Titan Pharmaceuticals (TTP) Announces Positive Phase III Clinical Results Evaluating Iloperidone Bristol-Myers Squibb (BMY) and Otsuka Pharmaceutical Announce Long-Term Maintenance Therapy in Adults With Bipolar I Disorder Using ABILIFY Boston …